Pay in 4 interest-free payments of $5.86 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
10.1016/j.ejmech.2013.09.054 63 KahkeshaniN.FarzaeiF.FotouhiM.AlaviS
The LEAD-1 study provided clinical input and compared glimepiride with two doses of liraglutide (1.2 mg and 1.8 mg) and rosiglitazone (4 mg) in patients with type 2 diabetes mellitus (T2DM) (16)
The advisory committee said yes
Can high-dose B12 therapy help alleviate diabetic neuropathy symptoms
As exendin 939 had the lowest IC 50 value for inhibiting CAP-activated TRPV1 currents, its molecular mechanism was further analyzed
Sanjay writes for Bloomberg.
US$ 25.87
US$ 22.02
US$ 29.79
US$ 29.97
US$ 24.51
US$ 24.11
